Clinical Trial Update: Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma [NA]

View source ↗

Summary

This study evaluates a combination of spatially fractionated radiotherapy, a PD-1 inhibitor, and anti-VEGF therapy for advanced hepatocellular carcinoma; the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• PD-1 inhibitor
• anti-VEGF therapy

Snippet

Sponsor: Guiping People's Hospital | Conditions: Hepatocellular Carcinoma, Radiotherapy | NA | Status: NOT_YET_RECRUITING